RASBURICASE
Formulary agent for management of hyperuricemia of malignancy utilizing a fixed dosing strategy (3mg for intermediate risk and 6mg for high risk).
Formulary agent for management of hyperuricemia of malignancy utilizing a fixed dosing strategy (3mg for intermediate risk and 6mg for high risk).